DERMAGRAFT HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE

FDA Premarket Approval P000036 S013

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Usage of two additional vacuum sealers during the packaging process.

DeviceDERMAGRAFT HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE
Generic NameDressing, Wound And Burn, Interactive
ApplicantSHIRE REGENERATIVE MEDICINE
Date Received2012-06-29
Decision Date2012-07-23
PMAP000036
SupplementS013
Product CodeMGR 
Advisory CommitteeGeneral & Plastic Surgery
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address SHIRE REGENERATIVE MEDICINE 11095 Torreyana Road san Diego, CA 92121

Supplemental Filings

Supplement NumberDateSupplement Type
P000036Original Filing
S018 2013-04-25 30-day Notice
S017 2013-04-24 30-day Notice
S016 2013-04-23 30-day Notice
S015
S014 2012-12-21 135 Review Track For 30-day Notice
S013 2012-06-29 30-day Notice
S012 2012-06-05 30-day Notice
S011 2012-04-23 135 Review Track For 30-day Notice
S010 2012-03-16 30-day Notice
S009 2012-03-16 30-day Notice
S008 2012-03-13 Normal 180 Day Track No User Fee
S007 2010-03-02 30-day Notice
S006 2008-10-31 30-day Notice
S005
S004
S003 2003-11-17 Special (immediate Track)
S002 2002-03-05 Special (immediate Track)
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.